- Home
- RGT vs ECOR Comparison
RGT vs ECOR Comparison
Compare RGT & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RGT | ECOR |
|---|---|---|
| Founded | 1986 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 94.4M | 81.0M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | RGT | ECOR |
|---|---|---|
| Price | $15.50 | $9.21 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $18.00 |
| AVG Volume (30 Days) | 17.4K | ★ 69.9K |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | ★ 1.43% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.92 | N/A |
| Revenue | N/A | ★ $32,032,000.00 |
| Revenue This Year | N/A | $33.60 |
| Revenue Next Year | N/A | $30.40 |
| P/E Ratio | $16.83 | ★ N/A |
| Revenue Growth | N/A | ★ 27.20 |
| 52 Week Low | $12.01 | $4.41 |
| 52 Week High | $15.65 | $10.50 |
Technical Indicators
Market Signals| Indicator | RGT | ECOR |
|---|---|---|
| Relative Strength Index (RSI) | 63.78 | 73.43 |
| Support Level | $13.97 | $8.55 |
| Resistance Level | N/A | $9.53 |
| Average True Range (ATR) | 0.23 | 0.78 |
| MACD | 0.04 | 0.41 |
| Stochastic Oscillator | 71.61 | 97.46 |
Price Performance
Historical ComparisonAbout RGT Royce Global Value Trust Inc.
Royce Global Value Trust Inc is a diversified closed-end investment company. The Fund spreads its investments across diversified sectors such as information technology, consumer discretionary, health care, materials, consumer staples and energy. Geographically, it has presence in the United Kingdom, Japan, the United States, Canada, France, Hong Kong and Germany.
About ECOR electroCore Inc.
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.